Tag: Biocon
Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in...
This partnership, which marks the entry of Biocon’s generic formulations into Latin America, builds upon a successful association with Libbs, which began in 2017 to launch biosimilar Trastuzumab in Brazil....................
Advancements in digital technology critical to advancements in clinical trials
As per experts, the digital-enabled regulatory flexibility during the pandemic that had helped bring drugs faster to market needs to continue.....................
New ‘Global Biopharma Resilience Index’ lists 5 major challenges for the...
The global index compiled by global life sciences leader Cytiva, along with the Financial Times’ research arm Longitude has been built on the survey of 1,165 biopharma executives and healthcare policymakers across 20 countries..................
Biocon Biologics partners IDF to increase access to diabetes care
Becomes the first biosimilar insulin company to partner with International Diabetes Federation for enabling affordable access to insulins to people with diabetes worldwide.................
Biocon Biologics to offer its oncology biosimilars in over 30 countries
The company's agreement with the Clinton Health Access Initiative (CHAI) to expand access to lifesaving cancer biosimilars will enable access to Trastuzumab and Pegfilgrastim in Africa and Asia...................
Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules...
A calcineurin inhibitor, Tacrolimus has been particularly effective in treating patients of renal transplant for more than two decades..............
Biological E unveils its Typhoid Conjugate Vaccine, manufacturing plant at Genome...
Biological E has invested Rs 300 Crore to build this Plant that will produce the Typhoid Conjugate Vaccine to protect children against typhoid fever, also generating employment for about 1000 people................
Syngene appoints Sibaji Biswas as CFO
Sibaji Biswas who brings more than twenty years of extensive experience in finance and related functions will be joining as the Chief Financial Officer and member of the Executive Committee from December 18, 2019..................
22 drugs in the market without approval, govt sends notices to...
The NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs. 5.56 crore has been recovered and demand notices amounting to Rs. 89.31 crore are under litigation....................
Riding on biologics wave, Biocon registers two fold growth during FY...
For the fiscal year ended March 2019, the Biocon's net profit rose over two-fold to Rs 905.3 crore as against Rs 372.4 crore for 2017-18. Company registered 64% growth in Q4 of FY19, earning 214 cr in net profits.................